A three-drug combination prevented the formation of HIV reservoirs in infant rhesus macaques, according to a report published by nplus1.ru on August 11, 2026. The findings suggest that early, aggressive treatment may stop the virus from hiding in the body.
The study, covered by nplus1.ru and other outlets including science.mail.ru and naukatv.ru, focused on newborn macaques exposed to a simian form of HIV. Researchers administered the triple therapy shortly after infection and found that the viral reservoir—the latent pool of virus that persists even during antiretroviral treatment—did not form.
According to nplus1.ru, this approach effectively cleared the virus from the animals' systems. The report describes the outcome as a potential path toward complete remission in human newborns, a concept echoed by Vesti.az, which noted that U.S. researchers had found a way to fully remove an HIV analog from animal bodies.
The significance lies in timing. In adults, HIV typically establishes reservoirs within days of infection, making eradication difficult. In newborns, however, the immune system and viral dynamics differ, and the window for intervention may be wider. The macaque results support the idea that starting treatment immediately after birth—before reservoirs take hold—could lead to a functional cure.
The triple-drug combination tested in this study builds on earlier work showing that early antiretroviral therapy can limit, but not always prevent, reservoir formation. The new data suggest that a specific combination of three agents may be more effective than standard regimens in very young subjects.
What to watch next: whether clinical trials in human infants can replicate these results, and whether the same strategy could apply to older children or adults with recently acquired HIV.
